» Authors » Jerome Pasquier

Jerome Pasquier

Explore the profile of Jerome Pasquier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 523
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pugliano C, Berger M, Ray R, Sapkos K, Wu B, Laird A, et al.
Mol Ther Methods Clin Dev . 2025 Feb; 32(3):101297. PMID: 40012884
Targeted gene editing to restore CD40L expression via homology-directed repair (HDR) in CD34 hematopoietic stem and progenitor cells (HSPCs) represents a potential long-term therapy for X-linked hyper IgM syndrome. However,...
2.
Papadakis G, Favre L, Zouaghi Y, Vionnet N, Niederlander N, Adamo M, et al.
J Transl Med . 2025 Jan; 23(1):138. PMID: 39885510
Background: Obesity is associated with varying degrees of metabolic dysfunction. In this study, we aimed to discover markers of the severity of metabolic impairment in men with obesity via a...
3.
de Goumoens V, Bruyere K, Rutz D, Pasquier J, Bettex Y, Vasserot K, et al.
J Fam Nurs . 2024 Sep; 30(3):255-266. PMID: 39268852
This study aimed to assess the feasibility of a complex family nursing intervention (SAFIR©) designed to support families of patients with acquired brain injuries during the early phase of hospitalization,...
4.
Luscher A, Vionnet N, Pasquier J, Chartoumpekis D, Mantziari S, Wojtsusizyn A, et al.
Surg Obes Relat Dis . 2024 Aug; 20(12):1187-1195. PMID: 39112103
Background: Postbariatric hypoglycemia (PBH) is a challenging condition affecting quality of life of patients after bariatric surgery. However, its incidence and predictive factors remain debated. Objectives: To determine the incidence...
5.
Bandiera C, Cardoso E, Locatelli I, Zaman K, Diciolla A, Digklia A, et al.
PLoS One . 2024 Jun; 19(6):e0304573. PMID: 38848380
Background: Oral anticancer therapies such as protein kinase inhibitors (PKIs) are increasingly prescribed in cancer care. We aimed to evaluate the impact of a pharmacist-led interprofessional medication adherence program (IMAP)...
6.
Bandiera C, Pasquier J, Locatelli I, Schneider M
JMIR Form Res . 2024 May; 8:e51013. PMID: 38776539
Background: Patient adherence to medications can be assessed using interactive digital health technologies such as electronic monitors (EMs). Changes in treatment regimens and deviations from EM use over time must...
7.
Legay C, Haeusermann T, Pasquier J, Chatelan A, Fuster D, Dhayat N, et al.
J Ren Nutr . 2023 Apr; 33(4):555-565. PMID: 37120128
Objective: Diet has a major influence on the formation and management of kidney stones. However, kidney stone formers' diet is difficult to capture in a large population. Our objective was...
8.
Papadopoulou V, Schoumans J, Basset V, Solly F, Pasquier J, Blum S, et al.
Hematology . 2023 Feb; 28(1):2180704. PMID: 36815747
Objective: IDH1/2 mutations, intervening in epigenetic procedures, are frequently encountered in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Knowledge of the genetics, immunophenotypes, and mutational kinetics of IDH1/2-mutated AML...
9.
Dzemaili S, Pasquier J, Bachmann A, Mohler-Kuo M
Int J Environ Res Public Health . 2023 Jan; 20(2). PMID: 36674060
Half to three-fourths of mental disorders appear during adolescence or young adulthood, and the treatment gap is mainly due to lack of knowledge, lack of perceived need, and the stigmatization...
10.
Santini S, Vionnet N, Pasquier J, Gonzalez-Rodriguez E, Fraga M, Pitteloud N, et al.
Obesity (Silver Spring) . 2022 Dec; 31(1):74-82. PMID: 36478514
Objective: This study investigated the effectiveness of liraglutide 3.0 mg daily in combination with a standardized multidisciplinary intervention on body weight and body composition changes in a real-life setting. Methods:...